Request for Public Comment: 60 Day Information Collection: Indian Health Service Forms To Implement the Privacy Rule, 3806-3807 [2016-01208]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
3806
Federal Register / Vol. 81, No. 14 / Friday, January 22, 2016 / Notices
Drug Administration, 10903 New
Hampshire Avenue, Bldg. 31, Rm. 2417,
Silver Spring, MD 20993–0002, 301–
796–9001, FAX: 301–847–8533, ACPS–
CP@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to 41 CFR 102–3.65 and approval by the
Department of Health and Human
Services pursuant to 45 CFR part 11 and
by the General Services Administration,
FDA is announcing the renewal of the
Pharmaceutical Science and Clinical
Pharmacology Advisory Committee. The
committee is a discretionary Federal
advisory committee established to
provide advice to the Commissioner.
The Pharmaceutical Science and
Clinical Pharmacology Advisory
Committee advises the Commissioner or
designee in discharging responsibilities
as they relate to helping to ensure safe
and effective drugs for human use and,
as required, any other product for which
the Food and Drug Administration has
regulatory responsibility.
The Committee reviews and evaluates
scientific, clinical, and technical issues
related to the safety and effectiveness of
drug products for use in the treatment
of a broad spectrum of human diseases;
the quality characteristics which such
drugs purport or are represented to
have, and as required, any other product
for which the Food and Drug
Administration has regulatory
responsibility; and makes appropriate
recommendations to the Commissioner
of Food and Drugs. The Committee may
also review Agency sponsored
intramural and extramural biomedical
research programs in support of FDA’s
drug regulatory responsibilities and its
critical path initiatives related to
improving the efficacy and safety of
drugs and improving the efficiency of
drug development.
The Committee shall consist of a core
of 14 voting members including two
Chairpersons. Members and
Chairpersons are selected by the
Commissioner or designee from among
authorities knowledgeable in the fields
of pharmaceutical sciences
(pharmaceutical manufacturing,
bioequivalence research, laboratory
analytical techniques, pharmaceutical
chemistry, physiochemistry,
biochemistry, molecular biology,
immunology, microbiology); clinical
pharmacology (dose-response,
pharmacokinetics-pharmacodynamics,
modeling and simulation,
pharmacogenomics, clinical trial design,
pediatrics and special populations and
innovative methods in drug
development); biostatistics, related
biomedical and pharmacological
specialties, current good manufacturing
VerDate Sep<11>2014
16:59 Jan 21, 2016
Jkt 238001
practices, and quality systems
implementation. Almost all non-Federal
members of this committee serve as
Special Government Employees. The
core of voting members may include one
technically qualified member, selected
by the Commissioner or designee, who
is identified with consumer interests
and is recommended by either a
consortium of consumer-oriented
organizations or other interested
persons. In addition to the voting
members, the Committee may include
up to three non-voting members who are
identified with industry interests.
Further information regarding the
most recent charter and other
information can be found at: https://
www.fda.gov/AdvisoryCommittees/
CommitteesMeetingMaterials/Drugs/
AdvisoryCommitteeforPharmaceutical
ScienceandClinicalPharmacology/ucm
107524.htm or by contacting the
Designated Federal Officer (see FOR
FURTHER INFORMATION CONTACT). Due to
a change in the committee name, FDA
will publish a final rule will in the
Federal Register amending 21 CFR
14.100.
This document is issued under the
Federal Advisory Committee Act (5
U.S.C. app.). For general information
related to FDA advisory committees,
please visit us at https://www.fda.gov/
AdvisoryCommittees/default.htm.
Dated: January 15, 2016.
Jill Hartzler Warner,
Associate Commissioner for Special
Programs.
[FR Doc. 2016–01181 Filed 1–21–16; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Request for Public Comment: 60 Day
Information Collection: Indian Health
Service Forms To Implement the
Privacy Rule
Indian Health Service, HHS.
Notice and request for
comments. Request for extension of
approval.
AGENCY:
ACTION:
In compliance with the
Paperwork Reduction Act of 1995, the
Indian Health Service (IHS) invites the
general public to comment on the
information collection titled, ‘‘IHS
Forms to Implement the Privacy Rule
(45 CFR parts 160 and 164),’’ Office of
Management and Budget (OMB) Control
Number 0917–0030.
DATES: Comment Due Date: March 22,
2016. Your comments regarding this
SUMMARY:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
information collection are best assured
of having full effect if received within
60 days of the date of this publication.
ADDRESSES: Send your written
comments, requests for more
information on the collection, or
requests to obtain a copy of the data
collection instrument and instructions
to Tamara Clay by one of the following
methods:
• Mail: Tamara Clay, Information
Collection Clearance Officer, Indian
Health Service, Office of Management
Services, Division of Regulatory Affairs,
5600 Fishers Lane, Mail Stop 09E70,
Rockville, MD 20857.
• Phone: 301–443–4750.
• Email: tamara.clay@ihs.gov.
• Fax: 301–443–2316.
SUPPLEMENTARY INFORMATION: This
previously approved information
collection project was last published in
the Federal Register (78 FR 2412) on
January 11, 2013, and allowed 30 days
for public comment. No public
comment was received in response to
the notice. This notice announces our
intent to submit the collection, which
expires April 30, 2016, to OMB for
approval of an extension, and to solicit
comments on specific aspects of the
information collection. A copy of the
supporting statement is available at
www.regulations.gov (see Docket ID
IHS–2016–1).
Title of Collection: 0917–0030, IHS
Forms to Implement the Privacy Rule
(45 CFR parts 160 and 164). Type of
Information Collection Request:
Extension of the currently approved
information collection, 0917–0030, IHS
Forms to Implement the Privacy Rule
(45 CFR parts 160 and 164). Form(s):
IHS–810, IHS–912–1, IHS–912–2, IHS–
913, and IHS–917. Need and Use of
Information Collection: This collection
of information is made necessary by the
Department of Health and Human
Services Rule entitled ‘‘Standards for
Privacy of Individually Identifiable
Health Information’’ (Privacy Rule) (45
CFR parts 160 and 164). The Privacy
Rule implements the privacy
requirements of the Administrative
Simplification subtitle of the Health
Insurance Portability and
Accountability Act of 1996, creates
national standards to protect
individual’s personal health
information, and gives patients
increased access to their medical
records. 45 CFR 164.508, 164.522,
164.526 and 164.528 of the Rule require
the collection of information to
implement these protection standards
and access requirements. The IHS will
continue to use the following data
collection instruments to meet the
E:\FR\FM\22JAN1.SGM
22JAN1
3807
Federal Register / Vol. 81, No. 14 / Friday, January 22, 2016 / Notices
information collection requirements
contained in the Rule.
45 CFR 164.508: This provision
requires covered entities to obtain or
receive a valid authorization for its use
or disclosure of protected health
information for other than for treatment,
payment and healthcare operations.
Under the provision individuals may
initiate a written authorization
permitting covered entities to release
their protected health information to
entities of their choosing. The form
IHS–810 ‘‘Authorization for Use or
Disclosure of Protected Health
Information’’ is used to document an
individual’s authorization to use or
disclose their protected health
information.
45 CFR 164.522: Section 164.522(a)(1)
requires a covered entity to permit
individuals to request that the covered
entity restrict the use and disclosure of
their protected health information. The
covered entity may or may not agree to
the restriction. The form IHS–912–1
‘‘Request for Restrictions(s)’’ is used to
document an individual’s request for
restriction of their protected health
information, and whether IHS agreed or
disagreed with the restriction. Section
164.522(a)(2) permits a covered entity to
terminate its agreement to a restriction
if the individual agrees to or requests
the termination in writing. The form
IHS–912–2 ‘‘Request for Revocation of
Restriction(s)’’ is used to document the
agency or individual request to
terminate a formerly agreed to
restriction regarding the use and
disclosure of protected health
information.
45 CFR 164.528 and 45 CFR 5b.9(c):
This provision requires covered entities
to permit individuals to request that the
covered entity provide an accounting of
disclosures of protected health
information made by the covered entity.
The form IHS–913 ‘‘Request for an
Accounting of Disclosures’’ is used to
document an individual’s request for an
accounting of disclosures of their
protected health information and the
agency’s handling of the request.
45 CFR 164.526: This provision
requires covered entities to permit an
individual to request that the covered
entity amend protected health
Number of
responses per
respondent
Average
burden hour
per response *
210,954
214
1
1
10/60
10/60
35,159
36
3
1
10/60
.5
39
1
10/60
6.5
54
1
10/60
9
211,264
........................
........................
35,211
Number of
respondents
Data collection instrument
Authorization for Use or Disclosure of Protected Health Information (OMB
Form No. 0917–0030, IHS–810) ..................................................................
Request for Restriction(s) (OMB Form No. 0917–0030, IHS–912–1) ............
Request for Revocation of Restriction(s) (OMB Form No. 0917–0030, IHS–
912–2) ..........................................................................................................
Request for Accounting of Disclosures (OMB Form No. 0917–0030, IHS–
913) ..............................................................................................................
Request for Correction/Amendment of Protected Health Information (OMB
Form No. 0917–0030, IHS–917) ..................................................................
Total Annual Burden .................................................................................
information. If the covered entity
accepts the requested amendment, in
whole or in part, the covered entity
must inform the individual that the
amendment is accepted. If the covered
entity denies the requested amendment,
in whole or in part, the covered entity
must provide the individual with a
written denial. The form IHS–917
‘‘Request for Correction/Amendment of
Protected Health Information’’ will be
used to document an individual’s
request to amend their protected health
information and the agency’s decision to
accept or deny the request. Completed
forms used in this collection of
information are filed in the IHS medical,
health and billing record, a Privacy Act
System of Records Notice. Affected
Public: Individuals and households.
Type of Respondents: Individuals.
Burden Hours: The table below provides
for this information collection: Types of
data collection instruments, estimated
number of respondents, number of
responses per respondent, average
burden hour per response, and total
annual burden hour(s).
Total annual
burden hours
mstockstill on DSK4VPTVN1PROD with NOTICES
* For ease of understanding, burden hours are provided in actual minutes.
The total estimated burden for this
collection of information is 35,211
hours. There are no capital costs,
operating costs and/or maintenance
costs to respondents.
Requests for Comments: Your written
comments and/or suggestions are
invited on one or more of the following
points:
(a) Whether the information collection
activity is necessary to carry out an
agency function;
(b) whether the agency processes the
information collected in a useful and
timely fashion;
(c) the accuracy of the public burden
estimate (the estimated amount of time
needed for individual respondents to
provide the requested information);
(d) whether the methodology and
assumptions used to determine the
estimates are logical;
VerDate Sep<11>2014
16:59 Jan 21, 2016
Jkt 238001
(e) ways to enhance the quality,
utility, and clarity of the information
being collected; and
(f) ways to minimize the public
burden through the use of automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Dated: January 13, 2016.
Robert G. McSwain,
Principal Deputy Director, Indian Health
Service.
[FR Doc. 2016–01208 Filed 1–21–16; 8:45 am]
BILLING CODE 4165–16–P
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
E:\FR\FM\22JAN1.SGM
22JAN1
]]>Agencies
[Federal Register Volume 81, Number 14 (Friday, January 22, 2016)]
[Notices]
[Pages 3806-3807]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-01208]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Indian Health Service
Request for Public Comment: 60 Day Information Collection: Indian
Health Service Forms To Implement the Privacy Rule
AGENCY: Indian Health Service, HHS.
ACTION: Notice and request for comments. Request for extension of
approval.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
Indian Health Service (IHS) invites the general public to comment on
the information collection titled, ``IHS Forms to Implement the Privacy
Rule (45 CFR parts 160 and 164),'' Office of Management and Budget
(OMB) Control Number 0917-0030.
DATES: Comment Due Date: March 22, 2016. Your comments regarding this
information collection are best assured of having full effect if
received within 60 days of the date of this publication.
ADDRESSES: Send your written comments, requests for more information on
the collection, or requests to obtain a copy of the data collection
instrument and instructions to Tamara Clay by one of the following
methods:
Mail: Tamara Clay, Information Collection Clearance
Officer, Indian Health Service, Office of Management Services, Division
of Regulatory Affairs, 5600 Fishers Lane, Mail Stop 09E70, Rockville,
MD 20857.
Phone: 301-443-4750.
Email: tamara.clay@ihs.gov.
Fax: 301-443-2316.
SUPPLEMENTARY INFORMATION: This previously approved information
collection project was last published in the Federal Register (78 FR
2412) on January 11, 2013, and allowed 30 days for public comment. No
public comment was received in response to the notice. This notice
announces our intent to submit the collection, which expires April 30,
2016, to OMB for approval of an extension, and to solicit comments on
specific aspects of the information collection. A copy of the
supporting statement is available at www.regulations.gov (see Docket ID
IHS-2016-1).
Title of Collection: 0917-0030, IHS Forms to Implement the Privacy
Rule (45 CFR parts 160 and 164). Type of Information Collection
Request: Extension of the currently approved information collection,
0917-0030, IHS Forms to Implement the Privacy Rule (45 CFR parts 160
and 164). Form(s): IHS-810, IHS-912-1, IHS-912-2, IHS-913, and IHS-917.
Need and Use of Information Collection: This collection of information
is made necessary by the Department of Health and Human Services Rule
entitled ``Standards for Privacy of Individually Identifiable Health
Information'' (Privacy Rule) (45 CFR parts 160 and 164). The Privacy
Rule implements the privacy requirements of the Administrative
Simplification subtitle of the Health Insurance Portability and
Accountability Act of 1996, creates national standards to protect
individual's personal health information, and gives patients increased
access to their medical records. 45 CFR 164.508, 164.522, 164.526 and
164.528 of the Rule require the collection of information to implement
these protection standards and access requirements. The IHS will
continue to use the following data collection instruments to meet the
[[Page 3807]]
information collection requirements contained in the Rule.
45 CFR 164.508: This provision requires covered entities to obtain
or receive a valid authorization for its use or disclosure of protected
health information for other than for treatment, payment and healthcare
operations. Under the provision individuals may initiate a written
authorization permitting covered entities to release their protected
health information to entities of their choosing. The form IHS-810
``Authorization for Use or Disclosure of Protected Health Information''
is used to document an individual's authorization to use or disclose
their protected health information.
45 CFR 164.522: Section 164.522(a)(1) requires a covered entity to
permit individuals to request that the covered entity restrict the use
and disclosure of their protected health information. The covered
entity may or may not agree to the restriction. The form IHS-912-1
``Request for Restrictions(s)'' is used to document an individual's
request for restriction of their protected health information, and
whether IHS agreed or disagreed with the restriction. Section
164.522(a)(2) permits a covered entity to terminate its agreement to a
restriction if the individual agrees to or requests the termination in
writing. The form IHS-912-2 ``Request for Revocation of
Restriction(s)'' is used to document the agency or individual request
to terminate a formerly agreed to restriction regarding the use and
disclosure of protected health information.
45 CFR 164.528 and 45 CFR 5b.9(c): This provision requires covered
entities to permit individuals to request that the covered entity
provide an accounting of disclosures of protected health information
made by the covered entity. The form IHS-913 ``Request for an
Accounting of Disclosures'' is used to document an individual's request
for an accounting of disclosures of their protected health information
and the agency's handling of the request.
45 CFR 164.526: This provision requires covered entities to permit
an individual to request that the covered entity amend protected health
information. If the covered entity accepts the requested amendment, in
whole or in part, the covered entity must inform the individual that
the amendment is accepted. If the covered entity denies the requested
amendment, in whole or in part, the covered entity must provide the
individual with a written denial. The form IHS-917 ``Request for
Correction/Amendment of Protected Health Information'' will be used to
document an individual's request to amend their protected health
information and the agency's decision to accept or deny the request.
Completed forms used in this collection of information are filed in the
IHS medical, health and billing record, a Privacy Act System of Records
Notice. Affected Public: Individuals and households. Type of
Respondents: Individuals. Burden Hours: The table below provides for
this information collection: Types of data collection instruments,
estimated number of respondents, number of responses per respondent,
average burden hour per response, and total annual burden hour(s).
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Data collection instrument Number of responses per hour per Total annual
respondents respondent response * burden hours
----------------------------------------------------------------------------------------------------------------
Authorization for Use or Disclosure of Protected 210,954 1 10/60 35,159
Health Information (OMB Form No. 0917-0030, IHS-
810)...........................................
Request for Restriction(s) (OMB Form No. 0917- 214 1 10/60 36
0030, IHS-912-1)...............................
Request for Revocation of Restriction(s) (OMB 3 1 10/60 .5
Form No. 0917-0030, IHS-912-2).................
Request for Accounting of Disclosures (OMB Form 39 1 10/60 6.5
No. 0917-0030, IHS-913)........................
Request for Correction/Amendment of Protected 54 1 10/60 9
Health Information (OMB Form No. 0917-0030, IHS-
917)...........................................
---------------------------------------------------------------
Total Annual Burden......................... 211,264 .............. .............. 35,211
----------------------------------------------------------------------------------------------------------------
* For ease of understanding, burden hours are provided in actual minutes.
The total estimated burden for this collection of information is 35,211
hours. There are no capital costs, operating costs and/or maintenance
costs to respondents.
Requests for Comments: Your written comments and/or suggestions are
invited on one or more of the following points:
(a) Whether the information collection activity is necessary to
carry out an agency function;
(b) whether the agency processes the information collected in a
useful and timely fashion;
(c) the accuracy of the public burden estimate (the estimated
amount of time needed for individual respondents to provide the
requested information);
(d) whether the methodology and assumptions used to determine the
estimates are logical;
(e) ways to enhance the quality, utility, and clarity of the
information being collected; and
(f) ways to minimize the public burden through the use of
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology.
Dated: January 13, 2016.
Robert G. McSwain,
Principal Deputy Director, Indian Health Service.
[FR Doc. 2016-01208 Filed 1-21-16; 8:45 am]
BILLING CODE 4165-16-P
